glp 1 science The GLP-1 journey: from discovery to therapeutic impact Glucagon-like peptide 1 (GLP-1) -

Dullaart, Hans B Biomolecules .2025

J Clin Endocrinol Metab (2015) 100(4):E61622.10.1210/jc.2014-4244 98 KoutroubakisIEOustamanolakisPMalliarakiNKarmirisKChalkiadakisIGanotakisEet alEffects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease

The most common retatrutide side effects are nausea (28%), diarrhea (24%), constipation (21%), and vomiting (17%), with symptoms peaking around weeks 6-8 before substantially improving by week 12

Kalra S, Bhattacharya S, Kapoor N

DPP-4 (not described in detail in this article) is the enzyme responsible for degrading native GLP-1 and GIP in the body

This leads to more precise questions and better answers